• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受微脉冲经巩膜激光治疗的青光眼患者的疼痛评估

Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy.

作者信息

Sukkee Janrapee, Taechajongjintana Natnaree, Ratanawongphaibul Kitiya, Itthipanichpong Rath, Manassakorn Anita, Tantisevi Visanee, Rojanapongpun Prin, Chansangpetch Sunee

机构信息

Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.

Center of Excellence in Glaucoma, Chulalongkorn University, Bangkok 10330, Thailand.

出版信息

J Clin Med. 2023 Mar 31;12(7):2634. doi: 10.3390/jcm12072634.

DOI:10.3390/jcm12072634
PMID:37048717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10095597/
Abstract

BACKGROUND

This study aimed to assess the pain experienced during micropulse transscleral laser therapy (MPTLT) and overnight thereafter and explore the factors associated with the pain.

METHODS

This prospective study included 100 eyes of 81 glaucoma patients undergoing MPTLT under retrobulbar anesthesia. All patients were asked to rate both types of pain using a numerical rating scale (NRS). The risk factors were explored using multivariable mixed-effects ordinal logistic regression.

RESULTS

The mean (SD) NRS pain score during the procedure was 3.57 (3.41) (range 0-10), which included no, mild, moderate, and severe pain in 30 (30%), 33 (33%), 17 (17%), and 20 (20%) eyes, respectively. The mean (SD) NRS score of overnight pain was 2.99 (2.28) (range 0-9), which included no, mild, moderate, and severe pain in 17 (17%), 59 (59%), 17 (17%), and 7 (7%) eyes, respectively. Twenty-seven (27%) eyes reported worse pain overnight than during the procedure. Increased age, initial intraocular pressure, and pain during the procedure were significantly associated with increased overnight pain ( < 0.05).

CONCLUSIONS

Up to a fourth of eyes had worse pain after discharge. Older age, initial intraocular pressure, and pain during the procedure were risk factors for higher levels of overnight pain.

摘要

背景

本研究旨在评估微脉冲经巩膜激光治疗(MPTLT)期间及之后过夜时所经历的疼痛,并探讨与疼痛相关的因素。

方法

这项前瞻性研究纳入了81例接受球后麻醉下MPTLT的青光眼患者的100只眼睛。所有患者均被要求使用数字评分量表(NRS)对两种类型的疼痛进行评分。使用多变量混合效应有序逻辑回归分析危险因素。

结果

手术过程中的平均(标准差)NRS疼痛评分为3.57(3.41)(范围0 - 10),其中30只眼(30%)无疼痛、33只眼(33%)轻度疼痛、17只眼(17%)中度疼痛、20只眼(20%)重度疼痛。过夜疼痛的平均(标准差)NRS评分为2.99(2.28)(范围0 - 9),其中17只眼(17%)无疼痛、59只眼(59%)轻度疼痛、17只眼(17%)中度疼痛、7只眼(7%)重度疼痛。27只眼(27%)报告过夜时疼痛比手术期间更严重。年龄增加、初始眼压以及手术期间的疼痛与过夜疼痛增加显著相关(<0.05)。

结论

多达四分之一的眼睛在出院后疼痛加剧。年龄较大、初始眼压以及手术期间的疼痛是过夜疼痛程度较高的危险因素。

相似文献

1
Assessment of Pain in Glaucoma Patients Undergoing Micropulse Transscleral Laser Therapy.接受微脉冲经巩膜激光治疗的青光眼患者的疼痛评估
J Clin Med. 2023 Mar 31;12(7):2634. doi: 10.3390/jcm12072634.
2
Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction.采用标准方案的微脉冲经巩膜睫状体光凝术治疗对环破坏术无反应的难治性青光眼患者。
Eur J Ophthalmol. 2021 Jan;31(1):112-119. doi: 10.1177/1120672119877586. Epub 2019 Sep 23.
3
Netarsudil as a Predictor of Response for MicroPulse Transscleral Laser Therapy: A Pilot Study.奈他舒地尔对微脉冲经巩膜激光治疗反应的预测作用:一项初步研究。
Ophthalmol Glaucoma. 2022 Nov-Dec;5(6):658-662. doi: 10.1016/j.ogla.2022.06.005. Epub 2022 Jun 14.
4
Transscleral cyclophotocoagulation with MicroPulse laser versus Ahmed valve implantation in patients with advanced primary open-angle glaucoma.经巩膜睫状体光凝术联合 MicroPulse 激光与 Ahmed 阀植入术治疗晚期原发性开角型青光眼。
Int Ophthalmol. 2021 Apr;41(4):1271-1282. doi: 10.1007/s10792-020-01682-0. Epub 2021 Jan 3.
5
Effectiveness of micropulse transscleral laser therapy in uncontrolled glaucoma secondary to ciliary body metastasis.微脉冲经巩膜激光治疗在睫状体转移继发的难治性青光眼中的有效性。
Am J Ophthalmol Case Rep. 2021 Aug 8;23:101190. doi: 10.1016/j.ajoc.2021.101190. eCollection 2021 Sep.
6
MicroPulse® transscleral laser therapy in the management of glaucoma patients.经巩膜微脉冲激光疗法治疗青光眼患者。
Arch Soc Esp Oftalmol (Engl Ed). 2021 Dec;96(12):640-648. doi: 10.1016/j.oftale.2020.12.005. Epub 2021 May 21.
7
Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma.微脉冲经巩膜睫状体光凝术治疗青光眼的早期结果
Eur J Ophthalmol. 2020 Jul;30(4):700-705. doi: 10.1177/1120672119839303. Epub 2019 Apr 2.
8
Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma.经巩膜睫状体光凝术联合 MicroPulse® 激光与联合连续二极管激光治疗开角型青光眼的比较。
Int Ophthalmol. 2022 Feb;42(2):525-539. doi: 10.1007/s10792-021-02023-5. Epub 2021 Oct 1.
9
Ciliochoroidal effusion and its association with the outcomes of micropulse transscleral laser therapy in glaucoma patients: a pilot study.睫状体脉络膜渗漏及其与青光眼患者微脉冲经巩膜激光治疗结局的关系:一项初步研究。
Sci Rep. 2022 Sep 30;12(1):16403. doi: 10.1038/s41598-022-20675-w.
10
Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up.难治性青光眼微脉冲经巩膜睫状体光凝术的临床疗效——18个月随访
Lasers Med Sci. 2020 Sep;35(7):1487-1491. doi: 10.1007/s10103-019-02934-x. Epub 2020 Jan 14.

本文引用的文献

1
Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic.在新冠疫情期间,微脉冲经巩膜睫状体光凝术作为台湾原发性开角型青光眼的主要手术治疗方法
Healthcare (Basel). 2021 Nov 17;9(11):1563. doi: 10.3390/healthcare9111563.
2
An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma.连续波光凝(CW-CPC)和微脉冲经巩膜激光治疗(MP-TLT)治疗成人和儿童难治性青光眼的最新进展。
Acta Ophthalmol. 2021 Aug;99(5):e621-e653. doi: 10.1111/aos.14661. Epub 2020 Nov 22.
3
Clinical Efficacy and Safety Outcomes of Micropulse Transscleral Diode Cyclophotocoagulation in Patients With Advanced Glaucoma.微脉冲经巩膜二极管光凝术治疗晚期青光眼的临床疗效和安全性结局。
J Glaucoma. 2021 Mar 1;30(3):257-265. doi: 10.1097/IJG.0000000000001729.
4
Micropulse Cyclophotocoagulation: A Multicenter Study of Efficacy, Safety, and Factors Associated With Increased Risk of Complications.微脉冲光凝术:一项关于疗效、安全性以及与并发症风险增加相关因素的多中心研究。
J Glaucoma. 2020 Dec;29(12):1126-1131. doi: 10.1097/IJG.0000000000001644.
5
Ocular Surface Pain: A Narrative Review.眼表疼痛:一篇叙述性综述。
Ophthalmol Ther. 2020 Sep;9(3):1-21. doi: 10.1007/s40123-020-00263-9. Epub 2020 Jun 5.
6
Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma.微脉冲经巩膜睫状体光凝术:使用低能量方案治疗难治性青光眼的初步结果。
Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1073-1079. doi: 10.1007/s00417-020-04611-0. Epub 2020 Feb 8.
7
Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up.难治性青光眼微脉冲经巩膜睫状体光凝术的临床疗效——18个月随访
Lasers Med Sci. 2020 Sep;35(7):1487-1491. doi: 10.1007/s10103-019-02934-x. Epub 2020 Jan 14.
8
Patient Safety and Quality for Office-Based Procedures in Otolaryngology.耳鼻喉科门诊手术的患者安全与质量
Otolaryngol Clin North Am. 2019 Feb;52(1):89-102. doi: 10.1016/j.otc.2018.08.015. Epub 2018 Sep 22.
9
Patient Outcomes Following Micropulse Transscleral Cyclophotocoagulation: Intermediate-term Results.微脉冲经巩膜睫状体光凝术后患者的转归:中期结果。
J Glaucoma. 2018 Oct;27(10):920-925. doi: 10.1097/IJG.0000000000001023.
10
In-office laryngeal procedures (IOLP) in Canada: current safety practices and procedural care.加拿大门诊喉部手术(IOLP):当前的安全实践和程序护理。
J Otolaryngol Head Neck Surg. 2018 Apr 3;47(1):23. doi: 10.1186/s40463-018-0270-2.